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CD8 T cell deﬁciency impairs
control of EpsteineBarr virus and
worsens with age in multiple
sclerosis
A large body of evidence indicates that
infection with the EpsteineBarr virus (EBV)
has a role in the pathogenesis of multiple
sclerosis (MS).
1 We have previously hypoth-
esised that a genetically determined defect in
the elimination of EBV-infected B cells by
cytotoxic CD8 T cells might predispose to
the development of MS by allowing EBV-
infected autoreactive B cells to accumulate in
the central nervous system (CNS).
12
Recently, we have shown that patients with
MS have a decreased frequency of CD8 T
cells reactive to their own EBV-infected B
cells.
3 Since 1980, it has been recognised that
MS patients have a decreased proportion and
number of CD8 T cells in peripheral blood.
4
This was initially interpreted as a decrease in
CD8 suppressor T cells leading to disinhibi-
tion of autoimmune responses but was later
attributed to sequestration of CD8 Tcells in
the CNS. An alternative explanation is that
the CD8 T cell deﬁciency is genetically
determined and causes the decreased CD8 T
cell response to EBV,
3 which allows the
accumulation of EBV-infected B cells in the
CNS and the consequent development of
MS. In the present study, we have used ﬂow
cytometry to determine the frequency of
CD8 Tcells in the blood and its relationship
to the EBV-speciﬁc T cell response and
clinical features of MS.
PATIENTS AND METHODS
Blood was collected from 64 MS patients and
68 age- and sex-matched healthy subjects
after obtaining informed consent. This study
was approved by the Royal Brisbane &
Women’s Hospital Human Research Ethics
Committee and The University of Queens-
land Medical Research Ethics Committee.
All patients met the 2005 Revised McDonald
Criteria for a diagnosis of MS. The clinical
course was relapsingeremitting (RRMS) in
23 patients, secondary progressive MS
(SPMS) in 25 patients and primary progres-
sive MS (PPMS) in 16 patients. The patients
had not received corticosteroids or immu-
nomodulatory therapy for at least 3 months
prior to venesection. Only two patients had
ever received immunosuppressive drugs and
these had been ceased 4 years before blood
collection. An additional seven patients had
received interferon-b, which had been ceased
6 months to 6 years before blood collection.
Peripheral blood mononuclear cells
(PBMCs) were separated by density centri-
fugation and cryopreserved, as previously
described.
3 For ﬂow cytometry, PBMC
samples were thawed and cultured for 24 h
to allow cells to rest and re-express cell
surface receptors. PBMC samples were
assessed using a Becton Dickinson FACSCa-
libur ﬂow cytometer to determine the
percentages of CD3 Tcells, CD4CD3 Tcells
and CD8CD3 T cells within the combined
lymphocyte and monocyte gates.
To measure the total T cell response to
EBV-infected B cells, we performed inter-
feron-g (IFN-g) enzyme-linked immunospot
assays to determine the frequency of PBMC
producing IFN-g in response to autologous
EBV-infected B cell lymphoblastoid cell lines
(LCLs), as previously described.
3 These
assays were performed on blood samples
that had been collected at the same time as
the samples used for ﬂow cytometry. CD8 T
cells are the predominant population
responding to LCLs in this enzyme-linked
immunospot assay, with the frequency of
EBV-speciﬁc T cells being ﬁve- to sevenfold
higher in the CD8 population than in the
CD4 population.
3
RESULTS
The mean percentage6SE of CD8 Tcells was
signiﬁcantly decreased in MS patients
(19.460.7) compared with healthy subjects
(22.760.8, p<0.01, ManneWhitney). The
decrease in CD8 T cells was more
pronounced in SPMS (18.861.0) and PPMS
(16.961.7) than in RRMS (21.761.1). Strik-
ingly, the proportion of CD8 Tcells declined
markedly with age in MS patients compared
with healthy subjects (ﬁgure 1A). This
decline was most marked in PPMS
(ﬁgure1B). Multiple linear regression analysis
demonstrated that patient age rather than
Kurtzke Expanded Disability Status scale
score or disease duration was the main
determinant of the proportion of CD8 Tcells
in MS patients (p<0.05).
The frequency of PBMC producing IFN-g
in response to autologous LCL was available
for 31 of the healthy subjects and 29 of the
MS patients from our previous study.
3 In the
healthy subjects, there was a strong positive
correlation between the LCL-speciﬁc T cell
frequency and the proportion of CD8 Tcells
in the blood, but this correlation was lost in
the MS patients (ﬁgure 1C). Figure 1C also
shows that for a given percentage of CD8 T
cells in the blood, the LCL-speciﬁc T cell
frequency in MS patients was generally
lower than in healthy subjects. This indi-
cates that the decreased LCL-speciﬁc T cell
frequency in MS is due to the CD8 T cell
deﬁciency and a decreased proportion of
LCL-speciﬁc T cells within the general CD8
T cell population. The LCL-speciﬁc T cell
frequency was lower in MS patients than in
healthy subjects at all ages but, in contrast
to the proportion of CD8 T cells, did not
decline with increasing age (ﬁgure 1D).
DISCUSSION
The present study conﬁrms the previously
reported CD8 T cell deﬁciency in patients
with MS
4 and shows that it contributes to
the decreased CD8 T cell response to EBV-
infected B cells and worsens with age. Our
ﬁnding that the CD8 Tcell deﬁciency is most
marked in SPMS and PPMS is consistent
with previous studies showing that the
decrease is most pronounced in progressive
MS.
4 What is remarkable about the CD8 T
cell deﬁciency in MS is that normally when
the EBV load is increased, as it is in the blood
and brain of MS patients,
1 the CD8 T cell
frequency should increase and not decrease.
5
This suggests that there is a fundamental
defect in the ability of MS patients to make
an appropriate CD8 Tcell response to EBV, as
we have previously hypothesised.
12
We propose that this defect is genetically
determined.
The absence of the normal correlation
between the LCL-speciﬁc T cell frequency
and the proportion of CD8 T cells in the
blood of MS patients (ﬁgure 1C) indicates
that, superimposed on the CD8 T cell deﬁ-
ciency, there is a deﬁciency of LCL-speciﬁc
T cells within the general CD8 T cell popu-
lation, which is most evident in SPMS. This
may reﬂect T cell exhaustion, which occurs
in virus-speciﬁc CD8 T cells during high-
grade chronic viral infections. We found a
marked aggravation of the CD8 T cell deﬁ-
ciency with increasing age in MS patients,
particularly in PPMS. CD8 T cells normally
decline slightly in number with increasing
age although this was not statistically
signiﬁcant in our healthy subjects, probably
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participants. The accelerated decline in the
proportion of CD8 T cells with age in MS
may partly result from deletion of EBV-
speciﬁc T cells through exhaustion but may
also be an intrinsic component of a genetic
CD8 Tcell deﬁciency. Accelerated age-related
CD8 T cell deﬁciency and the consequent
increasing EBV load might underlie the age-
dependent accumulation of disability in
MS.
6
In conclusion, we have shown CD8 Tcell
deﬁciency contributes to the decreased CD8
T cell response to EBV-infected B cells and
worsens with age in MS patients. These
ﬁndings have implications for the prevention
and treatment of MS by controlling EBV
infection.
1
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Figure 1 (A) Proportion of CD8 T cells in peripheral blood mononuclear cells (PBMCs) in healthy
control (HC) subjects and the total group of multiple sclerosis patients (All MS) plotted against age
in years. The proportion of CD8 T cells declines markedly with increasing age in the patients with
MS (continuous line) (r¼ 0.46, p¼0.0001, Pearson) but not in the healthy subjects (broken line)
(rs¼ 0.11, p¼0.26, Spearman). The slopes of the regression lines are signiﬁcantly different
(p<0.05, multiple linear regression). (B) Proportion of CD8 T cells in PBMCs in HC subjects and
patients with primary progressive MS (PPMS) plotted against age in years. The proportion of CD8
T cells declines markedly with age in patients with PPMS (continuous line) (r¼ 0.82, p<0.0001)
but not in healthy subjects (broken line). The slopes of the regression lines are signiﬁcantly different
(p<0.01). (C) Frequencies of T cells producing interferon-g (IFN-g) in response to autologous
EpsteineBarr virus (EBV) infected lymphoblastoid cell lines (LCLs) plotted against the proportion of
CD8 T cells in the blood of EBV-seropositive healthy subjects (HC) (broken line) and
EBV-seropositive patients with MS (continuous line). There is a signiﬁcant positive correlation
between the LCL-speciﬁc T cell frequency and the proportion of CD8 T cells in the healthy subjects
(r¼0.48, p<0.01) but not in the patients with MS (r¼0.04, p¼0.84). For a given proportion of CD8 T
cells in the blood, the LCL-speciﬁc T cell frequency in MS patients is generally lower than in healthy
subjects. This indicates that the decreased LCL-speciﬁc T cell frequency in MS is due to the CD8
T cell deﬁciency and a decreased proportion of LCL-speciﬁc T cells within the general CD8 T cell
population. The slopes of the regression lines are signiﬁcantly different (p<0.05). (D) Frequencies of
T cells producing IFN-g in response to autologous EBV-infected LCLs plotted against the age (in
years) of 34 EBV-seropositive healthy subjects (HC) (broken line) and 34 EBV-seropositive patients
with MS (continuous line). For HC, r¼0.25 and p¼0.15; for MS patients, r¼0.17 and p¼0.33. The y
intercepts (elevations) of the regression lines are signiﬁcantly different (p<0.01).
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